KBRA Affirms All Ratings for VRTX 2025-HQ
14 Aug 2026 | New York
KBRA affirms all ratings for VRTX 2025-HQ, a CMBS single-borrower transaction. The affirmations follow a surveillance review of the transaction, which has exhibited stable performance since securitization.
The collateral for the transaction is a $688.5 million portion of a $1.0 billion non-recourse, first lien mortgage loan secured by the borrower’s fee simple interest in Vertex HQ, which comprises two 15-story Class-A LEED Gold life science office buildings located in the Seaport District of Boston, Massachusetts. The buildings contain 1.1 million sf, which consists of approximately 52.3% of office space, 42.0% of lab space, 4.4% of retail space, and 1.3% of storage space. Additionally, the buildings have access to a 1,852-space underground parking garage, of which 740 spaces serve as collateral for the loan.
The fixed-rate loan has a five-year term and requires monthly interest-only payments based on an interest rate of 5.5957% with a September 2030 maturity date. The loan sponsor is Diversified Healthcare Trust (NASDAQ: DHC).
KBRA analyzed the cash flow for the properties utilizing information from the trustee and servicer to determine KNCF. The analysis produced a KNCF of $87.6 million and a KBRA value of $1.06 billion ($936 per sf). The resulting in-trust KLTV is 94.1%, which was in line with 94.2% at securitization. KBRA assigned a KPO of Perform to the loan.
To access ratings and relevant documents, click here.
Click here to view the report.